Issues with anti-Gr1 antibody-mediated myeloid-derived suppressor cell depletion
Ann Rheum Dis
.
2016 Aug;75(8):e49.
doi: 10.1136/annrheumdis-2016-209786.
Epub 2016 May 25.
Authors
Yan-Fang Xing
1
,
Yu-Qi Zhou
2
,
Guo-Wei Ma
3
,
Ding-Yun Feng
2
,
Xiu-Rong Cai
4
,
Xing Li
4
Affiliations
1
Department of Nephrology, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, People's Republic of China.
2
Department of Respiration, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, People's Republic of China.
3
Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Guangzhou, People's Republic of China.
4
Department of Medical Oncology, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, People's Republic of China.
PMID:
27226524
DOI:
10.1136/annrheumdis-2016-209786
No abstract available
Keywords:
Arthritis; Autoimmune Diseases; Inflammation; Rheumatoid Arthritis.
Publication types
Letter
Research Support, Non-U.S. Gov't
Comment
MeSH terms
CD11b Antigen*
Myeloid Cells
Myeloid-Derived Suppressor Cells*
Substances
CD11b Antigen